Raffles Medical Group Ltd (BSL.SI)
- Previous Close
1.0200 - Open
1.0100 - Bid 1.0000 x --
- Ask 1.0100 x --
- Day's Range
1.0100 - 1.0200 - 52 Week Range
0.9850 - 1.4700 - Volume
2,991,500 - Avg. Volume
1,388,296 - Market Cap (intraday)
1.876B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
20.20 - EPS (TTM)
0.0500 - Earnings Date Feb 26, 2024
- Forward Dividend & Yield 0.02 (2.38%)
- Ex-Dividend Date May 13, 2024
- 1y Target Est
1.15
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services segments. Its Raffles Hospital, a tertiary care hospital that offers a range of medical and surgical facilities include day angiography suites, operating theatres, delivery suites, intensive care unit, neonatal intensive care unit, radiology, clinical laboratory, and dental services. In addition, the company offers emergency services, family medicine services, health screening, minor surgery, and various specialist clinic services. Further, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services. Additionally, the company engages in the operation of medical and dental clinics and other general medical services; provides medical examination and treatment services; operation of medical laboratory and imaging centre; and provision of health insurance services. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. The company operates as a subsidiary of Raffles Medical Holdings Pte Ltd.
www.rafflesmedicalgroup.com2,892
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BSL.SI
Performance Overview: BSL.SI
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BSL.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BSL.SI
Valuation Measures
Market Cap
1.88B
Enterprise Value
1.64B
Trailing P/E
20.95
Forward P/E
27.32
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.67
Price/Book (mrq)
1.82
Enterprise Value/Revenue
2.32
Enterprise Value/EBITDA
10.02
Financial Highlights
Profitability and Income Statement
Profit Margin
12.73%
Return on Assets (ttm)
4.42%
Return on Equity (ttm)
8.79%
Revenue (ttm)
708.03M
Net Income Avi to Common (ttm)
90.15M
Diluted EPS (ttm)
0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
343.6M
Total Debt/Equity (mrq)
11.95%
Levered Free Cash Flow (ttm)
193.49M
Research Analysis: BSL.SI
Company Insights: BSL.SI
BSL.SI does not have Company Insights